First FET B2B euopean review
EC2019-09-04T12:59:07+00:00Back from the first successful review of B2B FET OPEN project in Brussels! Amazing work of the consortium coordinated by Silvia Scaglione.
Back from the first successful review of B2B FET OPEN project in Brussels! Amazing work of the consortium coordinated by Silvia Scaglione.
From 30 September to 2 October we will take part in the 25th IFSCC conference in Milan. We look forward to seeing you at our stand, boothG23.
Projects SME Phase 2 are very competitive. React4life obtained the Seal of Excellence: the European Commission H2020 Program recognized the value of our product MIVO® and its potential on the market!
From tomorrow we will take part in the 59th AFI (Associazione Farmaceutici Industria) Symposium, the most important event for the Italian pharmaceutical industry. We look forward to seeing you at the startup square on Thursday afternoon with a pitch by React4life.
We give full attention to the production of our MIVO multi in-vitro organ devices, which is why we rely exclusively on the best specialists in their fields, from 3D printing to packaging, carried out by the experts of one of the world’s major biomedical districts (Mirandola).
European Commission selected companies for the SME-Phase 2 inteviews: React4life is among the 15 italian companies convened! In the last cut-off date of January 2019 1752 proposal were submitted, and only 135 companies were involved in the interviews. Finally, 68 were selected for funding. Great result for React4life and its team! [...]
React4life was invited to the Startup Grind Europe Conference, to join the first round of the Startup Program for the Startup Exhibition in Europe! After a deep selection, we've been chosen with around other 100 startups coming from Europe, Middle East and all over the world, where just 5 Italian startups were selected! [...]
React4life is pleased to announce a new collaboration with MTTlab srl, to work on new methods of research in the biotech field. Both React4life srl and MTTlab srl will work together to expand your research.
Last week dissemination for European Commission and pitch of React4life to investors at FET2Rin event in Brussels (26 March 2019). The Future Emerging Technology project Breast-2-Bone and the economic impact: when innovation is able to open new markets.
On 3 and 4 April 2019, in Brussels, a limited hand-picked number of companies backed by the European Innovation Council (EIC) pilot will have the opportunity to pitch and present their business cases and to engage in one-on-one business meetings with representatives from some of the leading Corporates in Europe.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy